Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
SmartCella AB appoints Oskar Steneryd as new CFO
Niklas Prager, CEO of SmartCella, says: "It's a great pleasure to announce that Oskar is joining SmartCella. He has a stellar track record from investing in businesses in the biotech and life science space, a strong commercial focus, and a wealth of experience from financial leadership and reporting. He will be instrumental in building our Finance and Business Control function further as SmartCella is entering the next phase of expansion and market visibility. Having a CFO who combines…
PR Newswire
19/03/2024
Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom
XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea. The innovative sublingual spray is devised as an enabling technology to provide optimal conditions for cannabinoid uptake and efficacy. XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea. The innovative sublingual spray is devised as an enabling...
PR Newswire
19/03/2024
Electrolux Group publishes restated figures for the new business area structure
From the interim report for the first quarter of 2024, Electrolux Group will be reporting in accordance with the new business area structure. From the interim report for the first quarter of 2024, Electrolux Group will be reporting in accordance with the new business area structure. The appendix to this press release contains selected restated figures by business area, by quarter and for full year 2022 and 2023. The restated financial information can also be found on the Group's website:...
PR Newswire
19/03/2024
BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's…
"Being able to give hope and contribute to the treatment of patients affected by Alzheimer's disease is what has driven me throughout my research life," said Professor Lars Lannfelt. "It is inspiring to see how research in this field has now begun to take quantum leaps with the development of treatments such as lecanemab which demonstrated meaningful benefits to patients in the global Phase 3 Clarity AD trial using gold standard endpoints. Coupled with the introduction of modern…
PR Newswire
19/03/2024
Implantica wins another RefluxStop™ public tender in Europe, this time in Spain…
Dr. Ruiz de Adana adds, "Our patients who had the RefluxStop™ procedure report that they no longer have episodes of gastric reflux and experienced no side effects such as dysphagia almost one year after surgery. We also see no adverse events related to RefluxStop™ so far." He goes on to say, "With sustained outcomes, RefluxStop™ has the potential to become the new standard of care for patients with severe GERD." Dr. Ruiz de Adana adds, "Our patients who had the…
PR Newswire
19/03/2024
Mendus to present NK cell program progress at the Innate Killer Summit
Press Release Stockholm, Sweden, March 19, 2024Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, announces that it will present the progress of its NK cell program at the 9th Annual Innate Killer Cell Summit, a leading conference for NK cell-based therapies.Mendus Director of Research Satwinder Kaur Singh, PhD will be expert speaker at the 9 thAnnual Innate Killer Summit held March 18-20 in San Diego, CA, USA...
Nasdaq GlobeNewswire
19/03/2024
ObsEva Announces Update on Board of Directors
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024– ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women's health, today announced that, concurrent to the decision to wind-down the company's operations, Catarina Edfjäll, Ph.D. has decided to step down from the Board effective today.“We would like to warmly thank Catarina for her significant contribution to the company over...
Nasdaq GlobeNewswire
19/03/2024
IBA signs contract to install a Be-Efficient irradiation solution in Germany
Louvain-la-Neuve, Belgium, March 19, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial irradiation, announced today it has signed a contract for the installation of a Be-Efficient electron beam irradiation solution equipped with two Rhodotron ®accelerators in Germany. This Be-Efficient electron beam solution includes two Rhodotron ®accelerators, a Beagle® production line...
Nasdaq GlobeNewswire
19/03/2024
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory…
Dr. Fanning brings a wealth of experience in creating infectious disease pipelines by internal R&D and licensing As the CBO of AstriVax, he will lead the company's business development, including partnerships, collaborations and non dilutive funding to drive the pipeline forward and create value for future funding rounds. His initial focus will be on the company's candidate vaccine to treat chronic Hepatitis B and shape the future AstriVax vaccine pipeline.Leuven, Belgium, March...
Nasdaq GlobeNewswire
19/03/2024
Alma launches a special edition of Soprano Titanium with a breakthrough…
Engineered for efficiency and speed, the special edition of the award-winning world-leading hair removal platform leverages the benefits of three synergistic wavelengths to take the concept of speed to a whole new level with superior results: SHR, a clinically-proven, virtually painless method of laser hair removal enables effective and comfortable treatments for all skin types, 3D simultaneous lasing of the three most effective laser wavelengths for hair removal (755nm, 810nm, and 1064nm), and…
PR Newswire
19/03/2024
MCE 2024 Milan: Midea RAC Unveils Sustainable Solutions for Cooling, Heating…
Having achieved a remarkable global sales milestone of over 6.2 million units, Midea leads the charge in promoting their advanced R290 products, demonstrating an unwavering dedication to sustainability. At this exhibition, Midea introduced its R290 Combo product lineup and R290 multi-split research project for the first time. Midea has always been exploring the technical difficulties of the R290 one drive three multi-split system and has made initial progress in the refrigerant leakage sensor…
PR Newswire
19/03/2024
TELUS Mental Health Index: Alarming isolation and loneliness levels among young…
The World Health Organization (WHO) has declared loneliness to be a pressing global threat, with the effects of isolation and loneliness now being recognized and compared to well-known health risks such as smoking, obesity and lack of physical activity. In fact, the US surgeon general is saying that its mortality effects are equivalent to smoking 15 cigarettes a day. The World Health Organization (WHO) has declared loneliness to be a pressing global threat, with the effects of isolation...
PR Newswire
19/03/2024
Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept…
LEGEND achieved its primary efficacy endpoint by significantly lowering HbA1c level in both the lanifibranor arm and in the lanifibranor with empagliflozin arm compared to placebo.Statistical significance was also achieved on several markers of liver injury, markers of glucose and lipid metabolism, as well as hepatic steatosis.Patients treated with lanifibranor in combination with empagliflozin maintained a stable weight throughout the 24 weeks study, addressing the moderate,...
Nasdaq GlobeNewswire
18/03/2024
Near Infrared Imaging Market Projected to Reach $3.60 billion by 2030 -…
Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues. The technology's enhancement, driven by breakthroughs in detector sensitivity and sophisticated image analysis algorithms, is revolutionizing healthcare through improved image quality. The global rise in surgical procedures demanding minimally invasive diagnostics further leads to a…
PR Newswire
18/03/2024
New Purina study reveals 73% of pet owners view their pet as a best friend
The bond between pets and owners doesn't just include daily activities. When it comes to a family holiday, 48 per cent of pet owners take their pets with them. 4 per cent of these even make sure to take their pet abroad. The bond between pets and owners doesn't just include daily activities. When it comes to a family holiday, 48 per cent of pet owners take their pets with them. 4 per cent of these even make sure to take their pet abroad. Claire Robinson-Davies also said, "Pet owners are...
PR Newswire
18/03/2024
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Browse in-depth TOC on "Medical Robots Market" Browse in-depth TOC on "Medical Robots Market" 164 - Tables 47 - Figures 192 - Pages Medical Robots Market Scope: Soft tissue surgical robotic system is the fastest growing in the medical robots market in 2023. Based on type, the medical robots market is segmented into surgical robotic system, rehabilitation robotic systems, radiosurgery robotic systems, and hospital & pharmacy robotic systems. The surgical robotic...
PR Newswire
18/03/2024
Urbanization, Pollution, and a Shift toward Natural and Organic Products Fueling…
Download the Sample PDF report to explore key market insights and trends: Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19266 The trend toward natural and organic skincare products and the emergence of niche brands offering alternatives are also reshaping consumer preferences and expanding market opportunities. Specific markets likeIndia,China,Australia,Singapore, andCanadaare...
PR Newswire
18/03/2024
Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma…
Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21 at 9.00am CET. To join the live webcast, please clickhere.To register and receive access details for the conference call, please clickhere. Attachment 2024_Outlook_and_pro_forma_conference_call
Nasdaq GlobeNewswire
18/03/2024
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 18 March 2024– On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2023. Under the...
Nasdaq GlobeNewswire
18/03/2024
Surge in Adoption of Accurate Disease Diagnosis in Clinical Diagnostics…
Download the Sample PDF report to explore key market insights and trends: Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19253 Multiomic applications in agri-genomics are facilitating advanced crop breeding programs and bolstering agricultural productivity. Environmental monitoring and remediation sectors are embracing multiomic aspects to comprehend ecosystem dynamics and tackle pollution...
PR Newswire
18/03/2024
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 -…
Lipid-Nanoparticle-Based Genomic Medicines Market Report Scope: Lipid-Nanoparticle-Based Genomic Medicines Market Report Scope: List of Prominent Players in the Lipid-Nanoparticle-Based Genomic Medicines Market: Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2380 Lipid-nanoparticle (LNP) based genomic medications are an advanced method in the field of delivering drugs and genetic therapies. LNPs are utilized as carriers in these medications to...
PR Newswire
18/03/2024
Quotient Sciences Strengthens Its Top Team with Three New Appointments
New appointments include Dr. Andrew Lewis as Chief Scientific Officer, Kieron Hall as Chief Marketing Officer, and Eric Bironneau as Chief Business Officer who will each play a critical role in Quotient Sciences growth and strategic direction. New appointments include Dr.Andrew Lewisas Chief Scientific Officer,Kieron Hallas Chief Marketing Officer, and Eric Bironneau as Chief Business Officer who will each play a critical role in Quotient Sciences growth and strategic direction...
PR Newswire
18/03/2024
NeuroDerm Announces Publication of Positive Results from Phase 3 BouNDless Trial…
"Orally administered levodopa/carbidopa tablets remain the most essential pharmacological intervention in Parkinson's disease; however, over time, the reliability of its benefits can decrease, leading to the onset of motor fluctuations", said Professor Alberto Espay, Principal U.S. Investigator of the BouNDless trial and Director of the James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders at the University of Cincinnati. "We are encouraged by…
PR Newswire
18/03/2024
EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices
"We are excited to embark on this transformative journey with GH Labs," said Xicheng Xie, Co-Founder and Vice President of EDAN. "By harnessing the power of AI technology, we aim to make ultrasound examinations more accessible and affordable for communities worldwide." "We are excited to embark on this transformative journey with GH Labs," saidXicheng Xie, Co-Founder and Vice President of EDAN. "By harnessing the power of AI technology, we aim to make…
PR Newswire
18/03/2024
Altri Comunicati